+ The calculations use standard pharmaceutical formulas: concentration (mg/mL) = vial size water volume, and draw volume (mL) = target dose concentration
Space injections at least one inch apart and avoid areas with bruising, scarring, or irritation
Sublingual tirzepatide
Staresinic M1, Petrovic I, Novinscak T, Jukic I, Pevec D, Suknaic S, Kokic N, Batelja L, Brcic L, Boban-Blagaic A, Zoric Z, Ivanovic D, Ajduk M, Sebecic B, Patrlj L, Sosa T, Buljat G, Anic T, Seiwerth S, Sikiric P Stress in Gastrointestinal Tract and Stable Gastric Pentadecapeptide BPC 157
Short non-diabetic data support remaining at 2.5 mg when weight and insulin-resistance markers are already moving and tolerability favors a hold. The label still positions 2.5 mg as the starter before 5 mg, so it is a defensible low-dose floor for selected users rather than a replacement for the 5 mg obesity-trial floor